Two lots of OsteoDenx dietary supplement capsules are being recalled by bioQuad Life Sciences of Yorba Linda, California, because they contain milk that is not listed on the label, according to a company announcement posted by the U.S. Food and Drug Administration on Nov. 13, 2026.
The company said people with an allergy or severe sensitivity to milk risk a serious or life-threatening allergic reaction if they take the product. No illnesses have been reported to date, according to the announcement.
The company said the problem was found during a routine FDA inspection. The capsules contain lactoferrin derived from cow’s milk. The announcement said distribution has stopped until corrected cartons are available.
The product was distributed nationwide, the company said. It reached consumers through online orders at bioquad.com and Amazon.com, through resellers, and through a dental clinic in Redwood City, California. The sales period ran from Nov. 1, 2024, to Nov. 11, 2026.
OsteoDenx is sold in paperboard cartons holding either 30 or 60 capsules. Each carton shows its lot number and expiration date on the side panel. The affected lots are listed in the table below.
The company said people with a milk allergy or sensitivity should not take the product, and they may discard it. Customers who bought the affected lots may request a full refund or a replacement in corrected packaging.
People with questions can call bioQuad at (714) 660-1031, Monday to Friday, 9:30 a.m. to 5 p.m. Pacific Time, or email service@bioquad.com. The company said emails received after business hours or on weekends will be answered the next business day.
The announcement said the recall is being made with the knowledge of the FDA. It did not say how many units are affected.
